Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

This presents a challenge, however, given the multitude of vaccine approaches currently being tested and the even greater number of vaccine target antigens being evaluated. In a recent report by ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Clinical outcomes from a prospective study of comprehensive genomic testing in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the ...